Kezar Life Sciences, Inc. (KZR) Change in Cash (2017 - 2026)

Kezar Life Sciences has reported Change in Cash for 10 years, with the latest figure at -$5.6 million in Q1 2026.

• Quarterly Change in Cash fell 19.0% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.2 million (up 636.2% YoY) and the FY2025 annual result came in at $30.1 million, up 381.6% from the prior year.
• Change in Cash declined to -$5.6 million in Q1 2026 per KZR's latest filing, from $32.9 million in the prior quarter.
• Over five years, Change in Cash peaked at $66.5 million in Q2 2022 and troughed at -$40.9 million in Q3 2022.
• A 5-year average of $196882.4 and a median of -$2.6 million in 2025 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 1813.62% in 2022, down 1527.02% in 2022.
• Over 5 years, Change in Cash stood at -$24.0 million in 2022, then soared by 137.48% to $9.0 million in 2023, then decreased by 23.39% to $6.9 million in 2024, then soared by 378.06% to $32.9 million in 2025, then slumped by 117.15% to -$5.6 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$5.6 million, $32.9 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.